BenevolentAI

BenevolentAI is a global leader in developing and applying artificial intelligence (AI) for scientific innovation. The aim is to accelerate the process from invention to patient medication by developing AI to create new treatments for some of the 8,000 untreated diseases worldwide. Our team of technologists, AI researchers, and scientists build and apply AI throughout the entire drug discovery and development process. The technology unlocks the unknown by generating new concepts based on established facts, providing a different understanding of diseases, leading to inventive steps and genuine insights that drive the development of new drugs and therapies.